State Street Corp Cytokinetics Inc Transaction History
State Street Corp
- $2.21 Trillion
- Q1 2024
A detailed history of State Street Corp transactions in Cytokinetics Inc stock. As of the latest transaction made, State Street Corp holds 4,520,358 shares of CYTK stock, worth $239 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
4,520,358
Previous 5,893,358
23.3%
Holding current value
$239 Million
Previous $492 Million
35.59%
% of portfolio
0.01%
Previous 0.02%
Shares
17 transactions
Others Institutions Holding CYTK
# of Institutions
459Shares Held
108MCall Options Held
7.2MPut Options Held
6.2M-
Black Rock Inc. New York, NY12.4MShares$656 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$529 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD5.12MShares$271 Million0.22% of portfolio
-
Bank Of America Corp Charlotte, NC4.78MShares$253 Million0.03% of portfolio
-
Wellington Management Group LLP Boston, MA3.98MShares$210 Million0.05% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $4.98B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...